Ölgerðin Egill Skallagrímsson (OLGERD) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
25 Nov, 2025Executive summary
Revenue increased by 2% year-over-year to ISK 11.2 billion, driven by retail and corporate sales, while sales to quick-service chains declined and hotel/restaurant sales remained flat.
Net profit for the quarter was ISK 482 million, down ISK 481 million from the same period last year, mainly due to a one-time gain in 2023 from a revaluation of the Iceland Spring acquisition.
EBITDA decreased by 9% year-over-year to ISK 1,055 million, and EBIT fell by 14% to ISK 778 million.
Operating margin was pressured by increased wage and operating costs, which rose ISK 102 million above gross profit growth.
Financial highlights
Gross profit rose by 5.7% (ISK 239 million) year-over-year, attributed to higher beer sales share and increased sales of functional drinks.
Sales and marketing expenses increased by ISK 217 million, mainly due to intensified competition and new customer acquisition, with ISK 71 million related to Collab exports.
Net financial expenses increased by ISK 26 million, largely due to currency effects and higher interest rates, partially offset by lower leverage and favorable commercial paper issuance.
Equity at period end was ISK 15.8 billion, with an equity ratio of 48%.
Net interest-bearing debt including lease liabilities was ISK 5.8 billion, up ISK 75 million from year-end.
Outlook and guidance
Management continues to emphasize investments that reduce environmental impact, aiming for net zero emissions by 2040.
The company expects continued competitive pressure and is investing in product innovation and market expansion, especially for functional drinks.
Latest events from Ölgerðin Egill Skallagrímsson
- Q3 2025 saw robust domestic growth, new acquisitions, and a major group restructuring.OLGERD
Q3 202618 Dec 2025 - 2024 saw stable revenue, lower profit, and strategic moves for future growth.OLGERD
Q4 202518 Dec 2025 - EBITDA and profit declined on flat sales, but equity and strategic investments increased.OLGERD
Q2 202518 Dec 2025 - Sales grew 3.3% but EBITDA fell 8%; guidance unchanged amid acquisitions and new launches.OLGERD
Q1 202625 Nov 2025 - EBITDA and profit fell on higher costs, but assets and equity grew amid key investments.OLGERD
Q3 202525 Nov 2025 - Revenue up 2.7% year-over-year, but EBITDA and net profit declined on higher costs.OLGERD
Q2 202612 Oct 2025